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Abstract 
Background: The World Health Organization (WHO) recommends administration of surgical antimicrobial prophy‑
laxis (SAP) in cesarean section prior to incision to prevent surgical site infections (SSI). This study aimed to determine 
whether SAP administration following cord clamping confers an increased SSI risk to the mother.
Methods: Study design: Cohort. Setting: 75 participating Swiss hospitals, from 2009 to 2018. Participants: A total of 
55,901 patients were analyzed. Main outcome measures: We assessed the association between SAP administration 
relative to incision and clamping and the SSI rate, using generalized linear multilevel models, adjusted for patient 
characteristics, procedural variables, and health‑care system factors.
Results: SAP was administered before incision in 26′405 patients (47.2%) and after clamping in 29,496 patients 
(52.8%). Overall 846 SSIs were documented, of which 379 (1.6% [95% CI, 1.4–1.8%]) occurred before incision and 449 
(1.7% [1.5–1.9%]) after clamping (p = 0.759). The adjusted odds ratio for SAP administration after clamping was not 
significantly associated with an increased SSI rate (1.14, 95% CI 0.96–1.36; p = 0.144) when compared to before inci‑
sion. Supplementary and subgroup analyses supported these main results.
Conclusions: This study did not confirm an increased SSI risk for the mother in cesarean section if SAP is given after 
umbilical cord clamping compared to before incision.
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Manuscript at a glance
Why was this study conducted? This study is by far 
the largest study to assess the association between tim-
ing of surgical antimicrobial prophylaxis relative to cord 
clamping and surgical site infection in cesarean section 
patients.
What are the key findings? We were able to demon-
strate that the surgical site infection rate is not higher if 
the prophylaxis is administered after cord clamping. The 
same surveillance method was used over many years. The 
drop-out rate was low and the quality of the data very 
high due to a rigorous validation system.
Open Access
*Correspondence:  rami.sommerstein@extern.insel.ch; andreas.widmer@usb.
ch
1 Department of Infectious Diseases, Bern University Hospital, University 
of Bern, Freiburgstrasse, 3010 Bern, Switzerland
7 Department of Infectious Diseases, University Hospital Basel, Basel, 
Switzerland
Full list of author information is available at the end of the article
Page 2 of 9Sommerstein et al. Antimicrob Resist Infect Control           (2020) 9:201 
What does this study add to what is already known? 
The results of this large prospective study provide evi-
dence that the risk of surgical site infection for the 
mother in cesarean section is not increased if antimi-
crobial prophylaxis is given after umbilical cord clamp-
ing. This could be beneficial for the neonate’s developing 
microbiome.
Introduction
Surgical antimicrobial prophylaxis (SAP) for cesarean 
section provides a 60–70% reduction in postpartum 
endometritis and a 30–65% reduction in wound infec-
tions in women who undergo either elective or emergent 
cesarean delivery [1, 2]. The practice of administration of 
antimicrobials in cesarean delivery after umbilical cord 
clamping was common until 2013 [3]. The principal rea-
sons were to avoid exposure to betalactam antibiotics 
that interfere with Vitamin K, in particular moxalactam, 
leading to serious bleeding [4], and to not expose the 
newborn to other potential side effects of antibiotics so 
early in life.
In addition, antimicrobials could theoretically promote 
the selection of resistant organisms and potentially mask 
neonatal infection, complicating evaluation for neona-
tal sepsis [3]. Microbiome building is important for the 
children’s development. It is modulated and shaped by 
antibiotic treatment, the birth delivery mode and breast-
feeding [5–9]. One example is the strong association 
between childhood antibiotic exposure and incidence of 
Crohn’s disease [10].
The results of four meta-analyses concluded that 
administration of SAP before surgical incision signifi-
cantly reduces the risk of surgical site infection (SSI), 
leading to a change in the previous policy [11–14]. The 
latest systematic review including 6250 women with SAP 
after clamping versus administration prior to incision 
reported a 38% risk reduction of SSI [14]. Therefore, cur-
rent WHO recommendations support the administration 
of pre-incisional SAP for cesarean section procedures 
[15], based in part on a Cochrane review published in 
2014 [2]. Switzerland, as many other countries, changed 
its guidelines following the publication of evidence 
mentioned above, and therefore obstetricians started to 
increasingly administer SAP before clamping around the 
year 2012 [16, 17]. However, the review had limitations 
as it included studies from low-income as well as high-
income countries and did not exclude patients with pre-
existing infections [14]. Also, the absolute reduction in 
events of the composite infectious morbidity was low.
Recent data, including a large randomized trial, from 
general and cardiac surgery showed that administration 
of SAP very close to incision was not associated with an 
increased risk of SSI [18, 19]. The time interval between 
incision and cord clamping is around 2–8 min [20], a very 
short period to assume a huge difference in the risk of SSI 
between the two strategies.
In view of this, our aim was to estimate the additional 
risk for SSI, if SAP is given before incision versus after 
umbilical clamping in a large cohort. We used data gen-
erated from the Swiss SSI surveillance program, which 
includes on-site quality visits, uses standardized infection 
definitions, and is validated by board certified infectious 
diseases physicians [21, 22].
Patients and methods
Study design and setting
This is a multicenter analytic study of prospectively col-
lected data from the Swiss national SSI surveillance 
program [22]. We included data from 75 healthcare 
institutions in Switzerland between April 2009 and 
December 2018. Each participating hospital records 
surveillance data on three different intervention types 
during a selected period, and then includes all consecu-
tive patients. The surveillance includes data collection 
at discharge as well as rigorous post-discharge surveil-
lance 30 days after the intervention with additional chart 
review in case of suspected infection. All patients were 
contacted at least five times by employees from infec-
tion control before being considered “lost to follow-up”. 
Follow-up of routine post-discharge surveillance was 
> 89%. Staff members of the surveillance team periodi-
cally performed on-site audits to check data quality, as 
published elsewhere [21, 22]. Data were finally entered in 
the national database.
Participants
Inclusion criteria was participation in the surveillance 
program and undergoing cesarean section between 2009 
and 2018. Exclusion criteria were patients with preexist-
ing maternal infections, if SAP was not applied within 
60 min before/after incision, or if the single SAP agent 
was not cefuroxime, cefazolin, amoxicillin/clavulanate, or 
ceftriaxone. (Fig. 1).
Variables, outcomes, and data sources
The primary outcome was SSI (wound infection and/
or postpartum endometritis), stratified for SAP admin-
istration before incision or after clamping. Co-variables 
included age, Body mass index (BMI), American Society 
of Anesthesiologists (ASA) score, wound contamination 
class: clean-contaminated (standard for cesarean section) 
vs. contaminated (preterm rupture of the membrane 
without maternal signs of infection), year of surgery, 
SAP agent, emergent procedure, operation duration, 
hospital, and hospital bed-size. Minutes between SAP 
administration and incision were summarized by SAP 
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administration groups. The decision of SAP administra-
tion before incision/after clamping was in most cases 
decided at the level of the institution. In some institu-
tions, however, this was also a gynecologist’s decision. 
We accounted for these factors, by adjusting for center 
(clustering) and hospital size.
SSI cases were defined as patients with SSI according 
to Centers for Disease Control and Prevention (CDC) 
definitions [23]. (https ://www.swiss noso.ch/modul e/ssi-
surve illan ce/ueber -ssi-surve illan ce/das-modul /). Infec-
tion control specialists reviewed all patient data, and 
those patients with a suspected SSI were crosschecked 
by a dedicated physician. All supervising physicians—
the majority board-certified in infectious diseases - had 
attended a training course on SSI surveillance.
Data were electronically entered into a centralized 
database. Type of SSI—superficial incisional, deep inci-
sional or endometritis was recorded, as well as the 
pathogen (if available): Up to three different pathogens 
could be entered for each SSI. Clinicians were asked 
to enter the main causative pathogen as “first” patho-
gen, in cases where multiple organisms were identified. 
The data source for the variables was the Swissnoso SSI 
surveillance program. Primary data was obtained from 
the patient charts and telephone interviews with patients.
To analyze the influence of preoperative comorbid-
ity, ASA scores were grouped into 1, 2, and high score 
(3–5). Age was grouped into < 30, 30–40, and > 40 years. 
Regarding bed size, hospitals were grouped into < 200 
beds, 200–500 beds and > 500 beds.
Data reporting
According to current Swissnoso data regulations, the pri-
mary data cannot be made available in a public registry 
[24].
Statistical analysis
To investigate differences in terms of baseline character-
istics for those with SAP before incision and after clamp-
ing we used the χ2 or Wilcoxon tests. Unadjusted general 
additive models (GAM) were used to visualize the SSI 
rate relative to timing of surgical incision using the mgcv 
package / gam function in R [25]. To determine the effect 
of SAP administration before/after clamping on SSIs, 
covariate adjusted multilevel logistic regression models 
Fig. 1 Flowchart of patient inclusion. Abbreviations: SAP: Surgical antimicrobial prophylaxis, SSI: Surgical site infection
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clustering at the hospital level (random intercept) were 
fitted.
Two supplementary analyses were performed: for tim-
ing, periods relative to incision were grouped into dif-
ferent SAP timing windows (− 60 to − 30, − 29 to − 20, 
− 19 to − 10 [reference, as most SAP administrations 
before incisions were performed in this window], − 9 to 
incision; incision to 9, 10 to 20, 20 to 30, and 30 to 60). 
Secondary endpoints were the SSI outcomes superficial 
wound infections and deep infections (including deep 
wound infections and/or endometritis).
Several subgroup analyses were performed: First, two 
subgroup analyses were performed to ensure that admin-
istration of SAP after incision actually corresponded 
to administration after clamping, i.e., within 2–8 min 
[20]: For this reason, we first excluded cases with SAP 
administration in the 10 min after incision. The second 
subgroup excluded hospitals with variable SAP admin-
istrations before/after clamping. For this reason, SAP 
administration of every single institution reporting their 
data was screened. If > 90% of SAP administrations were 
performed either before or after incision, it was assumed 
that the institutions administered SAP consistently in 
the respective way and the cases were included in the 
subgroup analysis. Further subgroup analyses excluded 
patients with no information on BMI, as this variable 
was not mandatory and was collected in only 40% of all 
patients.
Missing data (including loss of follow-up) was investi-
gated by multiply imputing data assuming missingness 
was at random, using the MICE package in R [26].
A p-value < 0.05 was considered statistically significant 
throughout. All statistics and plots were created in R [25].
Results
Out of a total of 67,432 patients, 55,901 (82.9%) fulfilled 
the inclusion criteria (Fig.  1). SAP was administered 
before incision in 26′405 patients (47.2%) and after inci-
sion in 29,496 patients (52.8%). The histogram of SAP 
timing relative to incision demonstrates that peak admin-
istration after incision is slightly delayed, compatible with 
administration after clamping (Fig. 2) and reflecting the 
time interval between incision and cord clamping, which 
usually is well below 10 min [20]. The median age of the 
participants was 33 years [IQR 29–36] and in 21.8% the 
wound class was considered contaminated. Certain dif-
ferences in baseline variables were observed between the 
groups (Table 1). After 2014, more patients received SAP 
before incision, whereas large hospitals (> 500 beds) and 
ceftriaxone as SAP agent were more frequent in the after 
clamping group.
Overall, 846 SSIs were found. The majority (550, 65.0%) 
were superficial wound infections, followed by organ 
space infections (endometritis; 226, 26.7%) and deep 
wound infections (70, 8.3%). 379 (1.6%) of patients with 
SAP before the incision had SSI, compared to 449 (1.7%) 
of patients with SAP after clamping (p = 0.759).
There were no differences in the SSI rates between the 
two groups, stratified for the depth of infection (Addi-
tional file 1: Table 1).
The visual results from fitting an unadjusted GAM 
showed that SSI risk was stable between − 40 min to 
15 min after the incision. Between − 60 to − 40 min, as 
well as between 15 and 60 min relative to incision, the 
results suggest non-significant oscillation of the SSI 
risk (Fig.  3) and crude SSI rates for time windows were 
comparable.
In the adjusted multilevel model SAP administration 
after clamping was not significantly associated with an 
increased SSI rate (OR 1.14, 95% CI 0.96–1.36; p = 0.144). 
Co-variables independently associated with an increased 
risk of a SSI were contaminated wound class (OR 1.27, 
95% CI 1.07–1.50; p = 0.005), ASA score of 2 (compared 
to ASA score of 1; OR 1.22, 95% CI 1.00–1.48 p = 0.046), 
and increasing procedure duration (per 30 min; OR 1.33, 
95% CI 1.19–1.49; p < 0.001).
Age between 30 and 40 years (compared to < 30 years; 
OR 0.76, 95% CI 0.66–0.88; p < 0.001), and elective (vs. 
emergent) surgery (OR 0.57, 95% CI 0.49–0.68; p < 0.001) 
were associated with a decreased SSI risk (Table 2).
In the analysis of the 19,923 patients in which data on 
BMI was recorded and all further variables were avail-
able, the results were comparable with the main results 
and the proportion of SSI was similar at 1.85% (95% CI, 
1.67–2.05). However, increasing BMI was significantly 
associated with SSI risk (p < 0.001; Additional file  1: 
Table 2).
Fig. 2 Histogram of Surgical Antimicrobial Prophylaxis 
Administration Relative to Incision in Cesarean Section
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In the supplementary analyses for the secondary out-
comes, SAP administration after clamping was not sig-
nificantly associated with an increased risk of either 
superficial wound infections (adjusted OR 1.16, 95% CI 
0.93–1.44; p = 0.180) or the combined endpoint deep 
wound infections and endometritis (adjusted OR 1.07, 
95% CI 0.80–1.42 p = 0.661, Suppl Tables 3–4).
This remained unchanged for the patients with data on 
BMI (Additional file 1: Tables 5–6).
An adjusted supplementary analysis, with different 
timing windows, was unable to identify a specific tim-
ing window associated with the SSI outcome (Additional 
file 1: Table 7).
Next, we aimed at verifying that administration after 
incision is a reliable surrogate marker for administration 
after clamping. In the subgroup of the 15 hospitals 
(15,855 patients) that administered SAP in > 90% of pro-
cedures per hospital either before or after incision the 
adjusted OR of SSI risk for SAP administration after 
clamping was 0.84 (95% CI 0.54–1.30, p = 0.435), in line 
with the main analysis (Additional file  1: Table  8). Even 
when excluding the 17′205 patients that received SAP 
within 10 min after incision, the point estimates of this 
conservative approach lay above 1, but there was still 
no significant association (adjusted OR 1.10, 0.87–1.38, 
p = 0.420; Additional file 1: Table 9).
A stratified analysis (data not shown) demonstrated 
that for neither of the periods (before/after 2014) SSI was 
significantly associated with SAP administration pre inci-
sion/after clamping.
Table 1 Baseline and Procedural Characteristics, by Surgical Antimicrobial Prophylaxis Administration (Before Incision / 
After Cord Clamping)
Abbreviations
ASA American Society of Anesthesiologists
BMI Body mass index
IQR Interquartile range
SAP Surgical antimicrobial prophylaxis
a BMI NA: Before =15′510 (58.7%); After = 18′052 (61.2%)
b Duration NA: Before =144 (0.5%); After = 94 (0.3%)
Before incision After cord clamping p
n 26,405 29,496
Age (%) 0.043
 < 30 years 7891 (29.9) 8902 (30.2)
 30–40 years 16,631 (63.0) 18,346 (62.2)
 > 40 years 1883 (7.1) 2248 (7.6)
BMI in kg/m2, median [IQR])a 28.0 [25.2, 31.6] 27.3 [24.2, 30.9] < 0.001
SAP agent (%) < 0.001
 Amoxicillin + Clavulanate 3601 (13.6) 1770 (6.0)
 Cefazolin 9081 (34.4) 9073 (30.8)
 Ceftriaxone 782 (3.0) 5117 (17.3)
 Cefuroxime 12,941 (49.0) 13,536 (45.9)
Minutes between SAP administration and incision −15 [−25, −9] 10 [5, 15] < 0.001
Elective surgery = yes (%) 13,458 (51.0) 14,820 (50.2) 0.089
ASA Score (%) < 0.001
 ASA 1 4427 (16.8) 6862 (23.3)
 ASA 2 20,229 (76.6) 20,648 (70.0)
 ASA 3/4/5 1401 (5.3) 1514 (5.1)
 NA 348 (1.3) 472 (1.6)
Contaminated wound = yes (%) 5724 (21.7) 6440 (21.8) 0.663
Procedure duration in minutes (median [IQR])b 38 [29, 49] 37 [29, 48] < 0.001
Hospital bed size (%) < 0.001
 < 200 12,328 (46.7) 17,588 (59.6)
 200–499 11,497 (43.5) 5757 (19.5)
 500+ 2580 (9.8) 6151 (20.9)
Procedure after January 1, 2014 = yes (%) 18,081 (68.5) 9612 (32.6) < 0.001
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Staphylococci, Enterobacteriaceae, anaerobes, entero-
cocci and streptococci were the most frequently identi-
fied causative microorganisms of SSI. Supplementary 
Table 10 provides a descriptive overview of microorgan-
ism relative to SAP administration before incision/after 
clamping, and according to all SSI, as well as for deep 
wound infections and endometritis.
Five patients (0.01%) died during the 1 month follow-
up. None of the deaths were associated with an SSI. 




This largest prospective analytic study with excellent 
follow-up was unable to identify an additional significant 
risk if SAP was delayed after cord clamping. Our results 
show a basically unchanged SSI risk whether SAP is 
administered before or after clamping.
Of note, almost all estimates of the odds ratio were > 1, 
suggesting a numerical tendency to an increased risk in 
this group. Thus, the odds ratio of the main analysis does 
not rule out the possibility that the odds of an event may 
Fig. 3 Unadjusted Generalized Additive Model with Surgical Site 
Infection as the Dependent Variable and Timing Relative to Incision 
as the Predicting Variable. The predicted SSI rate including 95% 
confidence intervals for the risk of surgical site infection relative to 
timing of SAP administration is shown. The timepoint of incision 
is indicated with a dashed line. Abbreviations: SAP: Surgical 
antimicrobial prophylaxis, SSI: Surgical Site Infection
Table 2 Adjusted Mixed Effects Logistic Regression  Modela with Surgical Site Infection as the Dependent Variable
Abbreviations
ASA American Society of Anesthesiologists
LL Lower limit of 95% confidence interval
OR Odds Ratio
SAP Surgical antimicrobial prophylaxis
UL Upper limit of 95% confidence interval
a Complete cases only, n = 48,995
OR LL UL p
SAP administration after cord clamping (Ref = before incision) 1.140 0.956 1.360 0.144
Age group
 30–40 years (Ref = < 30 years) 0.760 0.657 0.879 < 0.001
 > 40 years (Ref = < 30 years) 0.852 0.640 1.134 0.272
Contaminated wound (Ref = clean, contaminated) 1.270 1.074 1.503 0.005
SAP agent (%)
 Cefazolin (Ref = Amoxicillin/clavulanate) 1.106 0.721 1.697 0.645
 Ceftriaxone (Ref = Amoxicillin/clavulanate) 0.939 0.544 1.619 0.821
 Cefuroxime (Ref = Amoxicillin/clavulanate) 1.031 0.687 1.547 0.882
Elective surgery (Ref = emergent) 0.574 0.488 0.676 < 0.001
ASA Score
 ASA 2 (Ref = ASA 1) 1.217 1.003 1.477 0.046
 ASA 3/4/5 (Ref = ASA 1) 1.326 0.952 1.846 0.095
Procedure duration (per 30 min increase) 1.330 1.189 1.488 < 0.001
Hospital bed size
 200–499 (Ref = < 200) 1.200 0.880 1.634 0.249
 500+ (Ref = < 200) 1.231 0.819 1.849 0.317
Procedure after Jan 2014 (Ref = before) 0.852 0.711 1.020 0.081
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be increased by up to 36%. Many unmeasured confound-
ers may have been present and the confidence intervals 
of the estimate are consistent with a potential increase in 
infection with administration after cord clamping.
In addition, our data show that factors other than tim-
ing of SAP administration were significantly associated 
with SSI risk. It was expected that increased procedure 
duration, increased BMI, high ASA score, contaminated 
wound and emergency operation were associated with an 
increased risk. The finding that age group of 30–40 years 
had a decreased risk in comparison to < 30 years may be 
due to a selection bias, as patients < 30 were more likely 
to have an emergent procedure and more frequently 
experienced premature rupture of the membranes. Of 
note, the choice of SAP agent did not play a significant 
role regarding SSI risk.
Results (internal and external validity)
The internal validity of our study was excellent, as hos-
pitals throughout Switzerland participated, including 
smaller institutions (< 200) and large centers (> 500) beds. 
The multilevel analysis approach with clustering at the 
hospital level allowed us to control for potential variation 
in SSI rate and reporting between the centers.
Concerning external validity, the analysis of large pro-
spective registries may be the ideal source for generating 
high-quality scientific data [27]. The overall SSI rate was 
low in our study (1.7%), compared to 4–5% reported by 
the WHO and the meta-analyses [2, 15] and up to 6–12% 
from a recent randomized controlled trial [28]. The dif-
ference could be explained by the fact that former studies 
included patients from developing countries in a different 
setting [2, 15]. In the latter study, the baseline character-
istics suggested a relevantly higher BMI (+ 8 kg/m2) and 
a higher rate of patients had already had ruptured mem-
branes, both important SSI risk factors after cesarean 
delivery [28]. As this is a national multi-center study with 
clustering at institutional level, we are convinced that our 
results can be transferred to similar health-care settings 
in resource rich countries, but this may not be the case 
for lower and middle income countries.
Even though other studies have shown a decreases 
SSI risk for SAP before incision, this was relatively small 
in absolute numbers: the Cochrane review reported 
38/2531 mothers developed an endomyometritis before 
clamping compared to 70/2510 after clamping. This 
potentially increased risk was not confirmed by our study 
and must be contrasted with a potential harm to the neo-
nate’s immune development [5–9]. Disrupted transmis-
sion of maternal Bacteroides strains to babies was even 
seen in vaginally delivered babies whose mothers under-
went antibiotic prophylaxis [9].
Finally, the potentially very short time interval between 
the two strategies argue against a relevant differential 
risk.
Clinical implications
These results challenge the latest WHO recommendation 
which extends the time window of SAP from 60 min to 
120 min prior to incision but does not consider adminis-
tration after clamping [29].
Research implications
In future research, the principally unchanged or slightly 
elevated SSI risk for the mother has to be balanced with 
long-term neonatal outcomes/microbiome development.
Strengths and limitations
The main strengths of our study were the standardized 
evaluation of SSI cases by dedicated physicians, a post-
discharge surveillance at 30 days, a mere < 10.4% loss of 
follow-up, routine on-site monitoring of the data col-
lection quality, and a multilevel model that permitted 
adjustment for SSI variation across the institutions. The 
main limitation of this study, was that the exact timing of 
clamping was not available and therefore administration 
after incision served as a surrogate marker. We believe 
we have sufficient evidence that SAP administration after 
incision corresponds to “after clamping”. First, clamping 
is done quickly after incision, usually within 5 min [20]. 
This is reflected in Fig.  2, where SAP application after 
incision peaks between 5 and 10 min after incision, com-
patible with administration after clamping. Moreover, a 
supplementary analysis failed to identify an optimal tim-
ing window within +/− 60 min relative to incision. In 
addition, we performed two subgroup analyses that made 
post-incisional SAP administration even more likely to 
represent “after clamping” administration, and the results 
are in line with the main analysis.
Other limitations of the study were the lack of detailed 
information concerning the individual surgeons, type of 
operating room, and patient comorbidities/characteris-
tics (such as diabetes, glycemic control, smoking, nutri-
tional status, intraoperative core temperature, estimated 
blood loss, and oxygen saturation), preoperative skin 
preparation procedures and/or the presence of SSI inter-
vention bundles. None of these variables are recorded in 
the Swissnoso database. In addition, data on antimicro-
bial treatment before and after surgery, group B strep-
tococcal carriage, multiple pregnancy, and/or vaginal 
disinfection were not routinely recorded.
The study period extended over 10 years, with potential 
changes in the management of cesarean section. How-
ever, cesarean section rates in Switzerland during this 
period remained constant at ~ 33% [30, 31], and surgical 
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technique has not significantly changed over this time 
period. Stratified analysis for the period before and after 
2014 did not provide arguments for a significant con-
founding by the two periods.
The variable BMI was only available in 40% of patients. 
Increasing BMI is a well-known risk factor for SSI [28, 
32, 33]. It might have been a confounding factor, but we 
performed several subgroup analysis with patients where 
BMI was available and the results were in line with the 
main analysis.
Conclusions
Results of this large prospective study provide evidence 
that the risk of SSI for the mother in cesarean section is 
similar for SAP given before incision or after umbilical 
cord clamping.
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